e-learning
resources
European Respiratory Review
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient
Egan J.J.
Source:
Eur Respir Rev 2011; 20: 114-117
Journal Issue:
June 2011 - 20 (120)
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Egan J.J.. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 2011; 20: 114-117
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias
Source: ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019
Year: 2019
Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019
Year: 2019
Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2014; 23: 3-4
Year: 2014
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Approach to diagnosis of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
Follow-up and nonpharmacological management of the IPF patient
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010
Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Steroid osteoporosis prevention in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013
The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Eur Respir J, 51 (1) 1702596; 10.1183/13993003.02596-2017
Year: 2018
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Towards a better diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 108-113
Year: 2011
Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept